Literature DB >> 15741366

Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.

Blanca E Gonzalez1, Gerardo Martinez-Aguilar, Kristina G Hulten, Wendy A Hammerman, Jorge Coss-Bu, Anna Avalos-Mishaan, Edward O Mason, Sheldon L Kaplan.   

Abstract

OBJECTIVE: More than 70% of the community-acquired (CA) staphylococcal infections treated at Texas Children's Hospital are caused by methicillin-resistant Staphylococcus aureus (MRSA). Since September 2002, an increase in the number of severely ill patients with S aureus infections has occurred. This study provides a clinical description of severely ill adolescent patients and an analysis of their isolates using molecular methods.
METHODS: We identified adolescent patients meeting criteria for severe sepsis requiring admission to the PICU. Patient records were reviewed, and isolates were obtained for susceptibility testing and DNA extraction. Isolates were tested for the presence of virulence genes (cna, tst, lukS-PV, and lukF-PV) and enterotoxin genes (sea, seb, sec, sed, seh, and sej) by polymerase chain reaction. Genomic fingerprints were determined by repetitive-element polymorphism polymerase chain reaction and pulse-field gel electrophoresis. SCCmec cassette type was determined.
RESULTS: Fourteen adolescents with severe CA S aureus infections were identified between August 2002 and January 2004. All were admitted to the PICU with sepsis and coagulopathy. Twelve patients had CA-MRSA infections; 2 had CA methicillin-susceptible Staphylococcus aureus (MSSA) infections. The mean age was 12.9 years (range: 10-15 years). Thirteen patients had pulmonary involvement and/or bone and joint infection; 10 patients had > or =2 bones or joints infected (range: 2-10); 4 patients developed vascular complications (deep venous thrombosis); and 3 patients died. All isolates were identical or closely related to the previously reported predominant clone in Houston, Texas (multilocus sequence type 8, USA300), and carried lukS-PV and lukF-PV genes as well as the SCCmec type IVa cassette (12 MRSA isolates) but did not contain cna or tst. Only 1 strain carried enterotoxin genes (sed and sej).
CONCLUSIONS: Severe staphylococcal infections in previously healthy adolescents without predisposing risk factors have presented more frequently at Texas Children's Hospital since September 2002. CA MRSA and clonally related CA MSSA characterized as USA300 and sequence type 8 have been isolated from these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741366     DOI: 10.1542/peds.2004-2300

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  94 in total

Review 1.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

2.  Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.

Authors:  Solen Pichereau; Madhulatha Pantrangi; William Couet; Cedric Badiou; Gerard Lina; Sanjay K Shukla; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Use of ribotyping to retrospectively identify methicillin-resistant Staphylococcus aureus isolates from phase 3 clinical trials for tigecycline that are genotypically related to community-associated isolates.

Authors:  Fionnuala McAleese; Ellen Murphy; Timothy Babinchak; Guy Singh; Battouli Said-Salim; Barry Kreiswirth; Paul Dunman; John O'Connell; Steven J Projan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin.

Authors:  B Keith English; Erik M Maryniw; Ajay J Talati; Elizabeth A Meals
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

5.  Rapid multiplex PCR assay for identification of USA300 community-associated methicillin-resistant Staphylococcus aureus isolates.

Authors:  Kristin K Bonnstetter; Daniel J Wolter; Fred C Tenover; Linda K McDougal; Richard V Goering
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

6.  Cyclooxygenase-2 enhances antimicrobial peptide expression and killing of Staphylococcus aureus.

Authors:  Jamie J Bernard; Richard L Gallo
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

Review 7.  Evidence-based approach to abscess management.

Authors:  Christina Korownyk; G Michael Allan
Journal:  Can Fam Physician       Date:  2007-10       Impact factor: 3.275

8.  Clinical outcomes and antibiotic susceptibilities of Staphylococcus aureus endophthalmitis.

Authors:  Jonathan I Huz; Krishna Mukkamala; Ivelisse Rodriguez Pagan; David Ritterband; Mahendra Shah; Ronald C Gentile; Michael Engelbert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-19       Impact factor: 3.117

Review 9.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.

Authors:  Kerry J Welsh; April N Abbott; Evan M Lewis; Jeanelle M Gardiner; Mark C Kruzel; Cole T Lewis; John F Mohr; Audrey Wanger; Lisa Y Armitige
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.